Ascentage pharma to report full year 2024 financial results and provide corporate update on march 27, 2025

Rockville, md. and suzhou, china, march 12, 2025 (globe newswire) -- ascentage pharma (nasdaq: aapg; hkex: 6855), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for hematological malignancies, today announced that it will release full year 2024 financial results, and provide an update on recent developments on march 27, 2025 at 7:00 am eastern daylight time (edt) / 7:00 pm hong kong time (hkt).
AAPG Quant Ranking
Sector
Industry